Medical Dermatology
Make the Diagnosis
November 2018
A healthy 70-year-old white male presented with a verrucous lesion on his left nose for several months.
From the Journals
Review finds some therapies show promise in managing prurigo nodularis
Among the most positive outcomes were those associated with newer treatments, including those targeting IL-31 signaling.
Conference Coverage
Consider different etiologies in patients with vaginal pruritus
CHICAGO – Vulvar itch is often multifactorial, so clinicians need to chip away at the potential causes.
From the Journals
Anti-RNPC3 antibody positive status linked to GI dysmotility in systemic sclerosis
Antibody status and other clinical and demographic variables could help to pin down who is most at risk of GI dysmotility.
Conference Coverage
Most dermatologic drugs safe for breastfeeding mothers
CHICAGO – Despite many physicians’ concerns, most dermatology drugs do not pose risks to the nursing infant or to...
Conference Coverage
Beware drug reactions from methotrexate, voriconazole, and BRAF inhibitors
MONTEREY, CALIF. – Two drugs – and a drug class commonly used in oncologic dermatology – can produce a variety of...
Conference Coverage
Sunscreens: Misleading labels, poor performance, and hype about their risks
MONTEREY, CALIF. – While they’re getting better, sunscreen quality varies and consumers face mixed messages, an...
News
FDA approves omadacycline for pneumonia and skin infections
The tetracycline antibiotic was approved for CABP and acute bacterial skin and skin structure infections in adults.
Conference Coverage
IgA vasculitis may be more common in adults than assumed
From the Journals
Pruritus linked to wide variety of cancers
The odds of specific cancers vary by race.
From the Journals
Skin signs may be good omens during cancer therapy
Vitiligo, rash, nail changes, and other cutaneous toxicities are associated with good clinical outcomes with three major classes of cancer...